HomeMDP • TSE
Medexus Pharmaceuticals Inc
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 29.99M | 18.96% |
Operating expense | 13.11M | 4.75% |
Net income | 733.00K | 237.27% |
Net profit margin | 2.44 | 215.09% |
Earnings per share | 0.03 | 250.00% |
EBITDA | 5.54M | 83.59% |
Effective tax rate | 16.70% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 8.44M | 2.78% |
Total assets | 145.98M | -8.98% |
Total liabilities | 112.88M | -13.71% |
Total equity | 33.10M | — |
Shares outstanding | 32.26M | — |
Price to book | 1.72 | — |
Return on assets | 6.49% | — |
Return on capital | 12.71% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 733.00K | 237.27% |
Cash from operations | 6.71M | 21.10% |
Cash from investing | -479.00K | 72.64% |
Cash from financing | -4.46M | 70.57% |
Net change in cash | 1.47M | 113.00% |
Free cash flow | 4.91M | 491.76% |
Previous close
$2.30
Day range
$2.14 - $2.30
Year range
$1.47 - $5.56
Market cap
69.35M CAD
Avg Volume
55.81K
P/E ratio
10.49
Dividend yield
-
Primary exchange
TSE
About
Founded
2013
Headquarters
Website
Employees
82
